FuelCell Energy Q2 Results Miss Estimates

Clean energy technology company FuelCell Energy, Inc. (FCEL) on Thursday reported a second-quarter net loss attributable to common stockholders of $31.02 million or $0.08 per share, wider than $19.72 million or $0.06 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/9eAFC2b
via IFTTT

Read More »

Campbell Soup Q3 Adj. Profit Rises, Organic Net Sales Up 9%; Reaffirms FY22 Adj. EPS Guidance

Campbell Soup Company (CPB) said the company had a strong recovery across the business in the third quarter with high-single-digit sales growth driven by sustained consumer demand for its brands and significantly improved supply. Looking forward, the company raised its fiscal 2022 net sales outlook reflecting strong year-to-date performance. However, the company reaffirmed prior adjusted EBIT and adjusted EPS guidance reflecting the on-going inflation-driven margin pressure.

from RTT - Earnings https://ift.tt/BV8Z3Gc
via IFTTT

Read More »

Cracker Barrel Guides Q4 Net Sales Growth Well Below Estimates; Declares Dividend - Update

While reporting financial results for the third quarter on Tuesday, Cracker Barrel Old Country Store, Inc. (CBRL) said it anticipates fourth-quarter revenue to be approximately 8.0% above the prior year fourth quarter.

from RTT - Earnings https://ift.tt/mt2bLIf
via IFTTT

Read More »

United Natural Foods Boosts FY22 Adj. EPS, Net Sales Outlook - Update

While reporting financial results for the third quarter on Tuesday, United Natural Foods, Inc. (UNFI) raised its adjusted earnings and net sales guidance for the full-year 2022.

from RTT - Earnings https://ift.tt/UHBRpC4
via IFTTT

Read More »

J. M. Smucker Guides FY23 Well Below Estimates - Update

While reporting financial results for the fourth quarter on Tuesday, consumer goods company J. M. Smucker Co. (SJM) initiated guidance for adjusted earnings and net sales growth for the full-year 2023.

from RTT - Earnings https://ift.tt/Z5xDdFO
via IFTTT

Read More »

COO Boosts Revenue Outlook, GTH On Watch, PHR Forecasts 27% To 29% Revenue Growth...

Phreesia Inc. (PHR), which provides healthcare organizations a suite of robust applications to manage the patient intake process, has reported strong financial results for the fiscal first quarter ended April 30, 2022.

from RTT - Earnings https://ift.tt/bOsV2Fq
via IFTTT

Read More »

AFMD To Report REDIRECT Data In Q4, VEEV Boosts EPS & Revenue Outlook, MESO At Work

Affimed N.V. (AFMD) expects to report topline data from its REDIRECT study in the fourth quarter of 2022. REDIRECT is a phase II, registration-directed study of its lead drug candidate AFM13 as monotherapy in patients with relapsed or refractory CD30-positive peripheral T-cell lymphoma.

from RTT - Earnings https://ift.tt/jdo8GuZ
via IFTTT

Read More »